Announcements Trials
Browse Landscape

Phase

Phase 1 8Phase 2 2Phase 1/2 2Phase NA 1Phase EARLY_PHASE1 1Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Dermatologic 1

Conditions

Melanoma 323Skin Neoplasms 164Carcinoma, Basal Cell 90Keratosis, Actinic 62Lymphoma, T-Cell, Cutaneous 60Breast Neoplasms 59Leukemia, Lymphocytic, Chronic, B-Cell 47Precursor Cell Lymphoblastic Leukemia-Lymphoma 46Mycosis Fungoides 46Lymphoma, Non-Hodgkin 46Sezary Syndrome 44Lymphoma, Follicular 44Lymphoma, Large B-Cell, Diffuse 43Lymphoma, B-Cell, Marginal Zone 43Lymphoma, Mantle-Cell 42Burkitt Lymphoma 42Hodgkin Disease 41Carcinoma, Squamous Cell 41Lymphoma, Large-Cell, Immunoblastic 40Neoplasms 39Multiple Myeloma 39Lymphoma 39Leukemia, Myeloid, Acute 35Leukemia, Myeloid, Accelerated Phase 32Myeloproliferative Disorders 31Leukemia, Myeloid, Chronic-Phase 31Congenital Abnormalities 30Leukemia, Hairy Cell 29Sarcoma 28Primary Myelofibrosis 28

Interventions

Risk Factors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Neoplasms, Squamous Cell × Dermatologic × Clear all
NCT03509467 2025-12-19

Using MC1R Genotype to Impact Melanoma Risk Behavior

H. Lee Moffitt Cancer Center and Research Institute

Phase NA Completed
2,054 enrolled 92 charts
Dermatologic

Carcinoma, Basal Cell, Carcinoma, Squamous Cell, Melanoma, Skin Neoplasms, Neoplasms, Basal Cell, Neoplasms, Squamous Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡